Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China
· Delayed Price · Currency is CNY 6.76
-0.05 (-0.73%)
May 9, 2025, 2:45 PM CST
SHE:002252 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 8,123 | 8,174 | 7,962 | 6,566 | 4,285 | 2,761 | Upgrade
|
| Other Revenue | 2.85 | 2.85 | 1.57 | 1.32 | 3.01 | 0.99 | Upgrade
|
| Revenue | 8,126 | 8,176 | 7,964 | 6,567 | 4,288 | 2,762 | Upgrade
|
| Revenue Growth (YoY) | 2.12% | 2.67% | 21.27% | 53.16% | 55.26% | 6.84% | Upgrade
|
| Cost of Revenue | 4,860 | 4,872 | 4,735 | 3,678 | 2,069 | 1,059 | Upgrade
|
| Gross Profit | 3,266 | 3,304 | 3,229 | 2,889 | 2,219 | 1,702 | Upgrade
|
| Selling, General & Admin | 862.68 | 867.79 | 712.75 | 706.48 | 616.64 | 528.98 | Upgrade
|
| Research & Development | 233.88 | 250.9 | 173.74 | 145.71 | 129.02 | 129.69 | Upgrade
|
| Other Operating Expenses | 80.02 | 48.65 | 31.49 | 32.81 | 23.05 | 20.36 | Upgrade
|
| Operating Expenses | 1,233 | 1,211 | 912.68 | 900.18 | 756.75 | 682.58 | Upgrade
|
| Operating Income | 2,033 | 2,093 | 2,316 | 1,989 | 1,462 | 1,020 | Upgrade
|
| Interest Expense | -0.43 | -0.22 | -0.12 | -0.26 | -0.47 | -0.38 | Upgrade
|
| Interest & Investment Income | 446.57 | 634.16 | 135.38 | 510.69 | 466.09 | 599.35 | Upgrade
|
| Currency Exchange Gain (Loss) | -85.01 | -85.01 | -43.34 | -56.55 | 11.28 | -9.95 | Upgrade
|
| Other Non Operating Income (Expenses) | 23.5 | -0.08 | -0.42 | -1.42 | -1.91 | -0.69 | Upgrade
|
| EBT Excluding Unusual Items | 2,418 | 2,642 | 2,408 | 2,441 | 1,937 | 1,608 | Upgrade
|
| Impairment of Goodwill | - | - | - | -197.02 | -361.19 | -129.68 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -196.89 | 18.38 | -42.76 | -17.58 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.45 | -1.61 | -0.01 | 0.23 | -1.35 | 0.97 | Upgrade
|
| Asset Writedown | -18.39 | -13.23 | -4.31 | -2.47 | -9.26 | -2.79 | Upgrade
|
| Other Unusual Items | -11.98 | -7.08 | -2.52 | 13.11 | 16.54 | 18.35 | Upgrade
|
| Pretax Income | 2,387 | 2,620 | 2,204 | 2,274 | 1,539 | 1,477 | Upgrade
|
| Income Tax Expense | 384.35 | 426.31 | 426.65 | 400.61 | 250.09 | 158.64 | Upgrade
|
| Earnings From Continuing Operations | 2,003 | 2,194 | 1,777 | 1,873 | 1,289 | 1,319 | Upgrade
|
| Minority Interest in Earnings | -0.38 | -0.5 | 2.04 | 7.09 | 5.56 | 5.12 | Upgrade
|
| Net Income | 2,003 | 2,193 | 1,779 | 1,880 | 1,295 | 1,324 | Upgrade
|
| Net Income to Common | 2,003 | 2,193 | 1,779 | 1,880 | 1,295 | 1,324 | Upgrade
|
| Net Income Growth | 10.17% | 23.25% | -5.35% | 45.24% | -2.21% | 117.75% | Upgrade
|
| Shares Outstanding (Basic) | 6,652 | 6,646 | 6,591 | 6,741 | 6,741 | 6,403 | Upgrade
|
| Shares Outstanding (Diluted) | 6,652 | 6,646 | 6,591 | 6,741 | 6,741 | 6,403 | Upgrade
|
| Shares Change (YoY) | 1.22% | 0.84% | -2.23% | - | 5.28% | 26.40% | Upgrade
|
| EPS (Basic) | 0.30 | 0.33 | 0.27 | 0.28 | 0.19 | 0.21 | Upgrade
|
| EPS (Diluted) | 0.30 | 0.33 | 0.27 | 0.28 | 0.19 | 0.21 | Upgrade
|
| EPS Growth | 8.84% | 22.22% | -3.19% | 46.80% | -8.09% | 72.28% | Upgrade
|
| Free Cash Flow | -826.49 | -889.2 | 1,827 | 1,500 | 1,089 | 917.09 | Upgrade
|
| Free Cash Flow Per Share | -0.12 | -0.13 | 0.28 | 0.22 | 0.16 | 0.14 | Upgrade
|
| Dividend Per Share | 0.070 | 0.070 | 0.030 | 0.030 | 0.028 | 0.025 | Upgrade
|
| Dividend Growth | 133.33% | 133.33% | - | 7.14% | 12.00% | 150.00% | Upgrade
|
| Gross Margin | 40.20% | 40.41% | 40.54% | 43.99% | 51.75% | 61.64% | Upgrade
|
| Operating Margin | 25.02% | 25.60% | 29.09% | 30.29% | 34.10% | 36.92% | Upgrade
|
| Profit Margin | 24.64% | 26.82% | 22.34% | 28.63% | 30.19% | 47.93% | Upgrade
|
| Free Cash Flow Margin | -10.17% | -10.88% | 22.94% | 22.84% | 25.41% | 33.21% | Upgrade
|
| EBITDA | 2,243 | 2,293 | 2,477 | 2,169 | 1,616 | 1,172 | Upgrade
|
| EBITDA Margin | 27.60% | 28.04% | 31.10% | 33.03% | 37.69% | 42.45% | Upgrade
|
| D&A For EBITDA | 209.36 | 199.57 | 160.39 | 180.33 | 154.07 | 152.76 | Upgrade
|
| EBIT | 2,033 | 2,093 | 2,316 | 1,989 | 1,462 | 1,020 | Upgrade
|
| EBIT Margin | 25.02% | 25.60% | 29.09% | 30.29% | 34.10% | 36.92% | Upgrade
|
| Effective Tax Rate | 16.10% | 16.27% | 19.36% | 17.62% | 16.25% | 10.74% | Upgrade
|
| Revenue as Reported | 8,126 | 8,176 | 7,964 | 6,567 | 4,288 | 2,762 | Upgrade
|
| Advertising Expenses | - | 193.47 | 143.4 | 193.23 | 169.52 | 98.94 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.